Official Title
Home-based Exercise Training in COVID-19 Survivors: a Randomized Controlled Trial
Brief Summary

The physical inactivity promoted by the patient's hospitalization, including those infected with the coronavirus, can lead to an important health impairment, including atrophy and loss of muscle function. Thus, a prospective study will be conducted to assess the effect of a home-based exercise training program on health outcomes and quality of life in COVID-19 survivors.

Recruiting
COVID19
SARS (Severe Acute Respiratory Syndrome)
SARS-CoV Infection

Other: Exercise training

A 16 weeks parallel-group randomised controlled trial will be performed, in which covid-19 survivors patients will complete a telemonitored home-based exercise training program, 3 times per week. The training program will involve strength, aerobic, balance and flexibility exercises.

Eligibility Criteria

Inclusion Criteria:

- Patients diagnosed with COVID-19

- Positive RT-PCR test and/or serology assay to detect IgG against SARS-CoV-2 in
addition to acute symptomatology compatible with the disease

- Admitted in intensive care unit

Exclusion Criteria:

- Cardiovascular disease

- Resting dyspnea

- Acute pulmonary embolism or pulmonary infarction

- Deep venous thromboembolism

- Uncontrolled visual or vestibular disorders

- Pregnancy

- Uncontrolled resting tachycardia

- Uncontrolled hypertension

- Uncontrolled Type II diabetes

- Acute infections

- Neurological disorders

- Patients with chronic kidney disease who are in need of hemodialysis

- Recent malignant neoplasm (<5 years)

- Autoimmune diseases

- Complex ventricular arrhythmias, atrial fibrillation or complete heart block

- Transplant patients

- Any physical disabilities that could hamper physical testing and exercise program

Eligibility Gender
All
Eligibility Age
Minimum: 40 Years ~ Maximum: 75 Years
Countries
Brazil
Locations

University of Sao Paulo
Sao Paulo, Brazil

Investigator: Bruno Gualano, Phd
Contact: 551130918783
gualano@usp.br

Investigator: Bruno Gualano, Phd

Contacts

Bruno Gualano, PhD
55112661 - 8021
gualano@usp.br

University of Sao Paulo
NCT Number
MeSH Terms
COVID-19
Severe Acute Respiratory Syndrome